Lutein and Zeaxanthin: Do Your Eyes Really Need Them?

Lutein and zeaxanthin are indeed relevant to eye health: they accumulate in the macula, the central area of the retina that provides the sharpest vision, and form a significant portion of macular pigment. But this doesn't mean everyone needs to take them in capsule form. For healthy people without age-related macular degeneration, there is no convincing evidence that supplements prevent vision loss or retinal disease. Current guidelines from the American Academy of Ophthalmology explicitly state that specific antioxidant-mineral supplements have no proven preventive value for people without evidence of age-related macular degeneration. [1]

The situation is quite different for certain stages of age-related macular degeneration. Here, there is a strong evidence base for the complete AREDS2 formula, which contains, among other things, 10 mg of lutein and 2 mg of zeaxanthin. It is recommended primarily for people with intermediate-stage disease and some patients with advanced stages. However, the evidence applies specifically to the complete formula, not to a generic "lutein for eyes" capsule. [2]

For cataracts, the results are considerably less impressive: in a large randomized trial, supplementing with 10 mg of lutein and 2 mg of zeaxanthin did not reduce the overall incidence of cataract surgery or prevent vision loss. In healthy individuals, supplements can increase macular pigment density and sometimes improve specific parameters such as contrast sensitivity or visual recovery after bright light, but there is no evidence yet that this translates into a significant reduction in the risk of blindness or the need for everyone to take supplements. [3]

So the practical answer is this: getting lutein and zeaxanthin through a varied diet is reasonable for almost everyone; taking supplements makes sense primarily when there is a specific ophthalmological indication.

What are lutein and zeaxanthin and why are they found in the eye?

Lutein and zeaxanthin are carotenoids—plant-derived pigments. Unlike beta-carotene, they are not used by the body primarily as a source of vitamin A. Their unique feature is that the body selectively concentrates these substances in the retina, particularly the macula. Together with meso-zeaxanthin, they form the macular pigment. [4]

Macular pigment absorbs some short-wavelength visible light before it reaches the light-sensitive cells of the retina, and carotenoids themselves have antioxidant properties. This creates a plausible biological mechanism by which they may participate in protecting macular tissue from oxidative stress. [5]

However, the presence of a substance in tissue does not necessarily prove that increasing its concentration with supplements will improve human health. Calcium is essential for bones, but this does not mean that everyone benefits from high doses of calcium. The same principle applies to lutein and zeaxanthin: it is necessary to demonstrate for whom the supplement benefits, at what dose, and for what clinically significant outcome.

This is why it's important to distinguish between three levels of evidence: increased blood carotenoid levels, increased macular pigment density, and actual prevention of vision loss or disease progression. The first two indicators are relatively easy to improve; the third—much more important for the patient—has only been proven in certain clinical situations. [6]

Does a healthy person need supplements?

For healthy adults with normal retinas, the need for lutein and zeaxanthin supplements has not been proven. They can be obtained from food, and there is no official recommended daily intake (RDI) for these carotenoids for the healthy population, similar to those for vitamin C or iron. Lutein is considered more of a biologically active food component than an essential nutrient with a proven deficiency syndrome. [7]

The current 2025 American Academy of Ophthalmology guidelines are particularly important in this regard. They explicitly state that the AREDS2 formula has no proven preventive value for relatives of patients with age-related macular degeneration unless they themselves have evidence of the disease, and do not support its use in stages below intermediate. [8]

This means that a parental history of age-related macular degeneration or a fear of “maintaining the retina after age 50” are not, in themselves, grounds for starting the high-dose AREDS2 formula.

The situation is somewhat more lenient with conventional supplements containing only lutein and zeaxanthin: studies in healthy people show that they can indeed increase macular pigment. A systematic review of 46 studies with over 3,000 participants found a dose-dependent increase in its optical density, especially with a combined lutein and zeaxanthin intake of 5 mg per day or more. However, the authors themselves emphasized that it remains unclear to what extent this change is clinically significant and whether it improves long-term eye health. [9]

In other words, the answer to the question "Does the supplement increase macular pigment?" is usually yes. The answer to the much more important question "Does every healthy person therefore need to take it for decades?" is not yet clear.

Can lutein improve vision in healthy people?

Sometimes individual parameters of visual function improve, but this does not mean an increase in normal visual acuity in every person.

A randomized trial of healthy young adults given 10 mg of lutein and 2 mg of zeaxanthin daily for a year showed an increase in macular pigment, as well as improved visual recovery from bright light and some measures of contrast perception. This was based on fine-grained functional tests, not on converting 0.8 to 1.0 vision or eliminating the need for glasses. [10]

A larger systematic review and meta-analysis of randomized trials also found increases in macular pigment density and some improvements in contrast sensitivity after xanthophyll-rich foods or supplements. However, the improvement in standard visual acuity was greater in participants with eye diseases than in healthy individuals. [11]

This helps us correctly interpret the advertising phrase "improves vision." While the supplement may indeed change some measurable characteristics of the visual system, this doesn't necessarily mean it will significantly improve vision in everyday life in a healthy person.

What the AREDS2 study actually proved

The AREDS2 study is often oversimplified as "lutein and zeaxanthin protect the eyes." In reality, the design and findings are much more specific.

The study included 4,203 people aged 50–85 years who were already at high risk for age-related macular degeneration progression: intermediate-stage disease in both eyes, or intermediate-stage disease in one eye and late-stage disease in the other. Participants were randomly assigned to receive 10 mg of lutein and 2 mg of zeaxanthin, omega-3 fatty acids, a combination of the two, or a placebo on top of a basic antioxidant-mineral formula. [12]

In the primary analysis, simply adding lutein and zeaxanthin to the original AREDS formula did not provide a statistically significant additional reduction in the risk of late macular degeneration. This is a very important fact that is often omitted from supplement advertising. [13]

However, the study also tested replacing beta-carotene with lutein and zeaxanthin. The results were more compelling: a formula without beta-carotene but with lutein and zeaxanthin showed benefits, while in former smokers, beta-carotene was associated with a higher incidence of lung cancer. Subsequent analyses and a ten-year follow-up confirmed that lutein and zeaxanthin are a more suitable replacement for beta-carotene. [14]

After ten years, the risk of progression to late age-related macular degeneration was slightly lower among those initially randomized to lutein and zeaxanthin; when compared directly with beta-carotene, the result also favored lutein and zeaxanthin. Conversely, the risk of lung cancer was almost twice as high among participants initially receiving beta-carotene, primarily due to former smokers. [15]

Who is the AREDS2 formula really recommended for?

Current recommendations link the formula not to age per se, but to the stage of age-related macular degeneration.

Situation	What the evidence says	Practical conclusion
Healthy retina, no age-related macular degeneration	There is no proven preventative benefit from the AREDS2 formula.	Usually, the supplement is not needed only for “prevention”
Early stage of the disease	Current guidelines do not consider the supplement a proven treatment.	Monitoring, smoking cessation, healthy eating and risk factor control
Intermediate stage in one or both eyes	The benefits of the full AREDS2 formula are best documented	Discuss an appointment with an ophthalmologist
Late stage in one eye	The formula may reduce the risk of progression of the second eye	AREDS2 is usually considered for use
Geographic atrophy	New data and 2025 guidelines support use in some patients	The decision depends on the location and stage of the disease.
Cataract without macular degeneration	No general prophylactic effect has been shown for cataract surgery.	Do not take AREDS2 solely for cataract prevention
A lot of time on the computer or phone	There are no clinical data to recommend AREDS2 for screening purposes.	Breaks, blinking, and vision correction are more important

This grading is consistent with the current guidelines of the American Academy of Ophthalmology and the data of the US National Eye Institute. [16]

What is included in the real AREDS2 formula?

AREDS2 is more than just lutein and zeaxanthin. The standard formula studied contains several components.

Component	Daily amount in the AREDS2 formula
Vitamin C	500 mg
Vitamin E	400 international units
Zinc	80 mg
Copper	2 mg
Lutein	10 mg
Zeaxanthin	2 mg
Beta-carotene	absent

This is the composition recommended by the US National Eye Institute. Copper was included to reduce the risk of copper deficiency with high zinc intake. [17]

This has significant practical implications. If a doctor recommends AREDS2 to someone with intermediate age-related macular degeneration, buying a regular 20 mg lutein capsule is not proven equivalent to this formula.

The reverse logic is also incorrect: a healthy person should not take the entire high-dose formula simply because lutein is considered beneficial for the macula. Its vitamin E and especially zinc content are significantly higher than the typical dietary intake, so the formula is intended for a specific group of patients, not as a universal multivitamin. [18]

Why was beta-carotene replaced with lutein and zeaxanthin?

The original AREDS formula contained beta-carotene. It later became clear that high-dose beta-carotene increases the risk of lung cancer in smokers, so AREDS2 replaced it with lutein and zeaxanthin. [19]

A ten-year follow-up of AREDS2 participants reinforced this recommendation. Among people initially receiving beta-carotene, the risk of lung cancer was higher, especially among former smokers, while no such increase was observed with lutein and zeaxanthin. At the same time, the new combination was at least as effective against macular degeneration and, in some comparisons, was superior. [20]

Therefore, it is especially important for current or former smokers to avoid older beta-carotene formulas when it comes to supplements for age-related macular degeneration. The current AREDS2 formula does not contain beta-carotene. [21]

New data on late-onset dry macular degeneration

In 2024, an important follow-up analysis of the AREDS and AREDS2 data was published. Researchers re-examined images of patients with geographic atrophy—the late, dry form of age-related macular degeneration—and assessed not just the increase in the area of atrophy, but its progression toward the fovea, the area responsible for the sharpest central vision. [22]

In patients whose atrophy was initially located outside the most central zone, taking the antioxidant formula was associated with an approximately 55 percent slowdown in the progression of atrophy toward the center over an average period of about three years. If atrophy was already located directly in the central region, the benefit was significantly less. The study was a reanalysis of existing data, not a new prospective randomized trial, so the results require cautious interpretation. [23]

However, these data have already been reflected in the current 2025 guidelines of the American Academy of Ophthalmology, where an antioxidant-mineral formula is recommended to be considered not only in the intermediate stage, but also in geographic atrophy and some variants of late macular degeneration. [24]

This is a good example of how the evidence base is changing: it was previously believed that after the development of the late dry stage, the benefits of the formula practically end, but new data suggest that the effect continues in some patients.

What is known about the early stage of the disease?

Here the evidence is less clear.

The current 2025 American Academy of Ophthalmology guidelines still state that there is no proven cure for early age-related macular degeneration, and the AREDS2 formula is not recommended for people below intermediate stage solely to prevent further progression.[25]

In 2026, a more recent meta-analysis of nine small randomized trials with 860 participants was published. It found increases in macular pigment, contrast sensitivity, and some improvements in corrected visual acuity after lutein supplementation, especially in early-stage disease. However, these studies primarily assessed intermediate outcomes and were significantly smaller in size than AREDS2. Currently, such results provide a basis for further research rather than overturning clinical guidelines. [26]

This is a fundamentally important distinction between “a biological effect has been detected” and “there is a basis for recommending the drug to the entire group of patients.”

Do lutein and zeaxanthin prevent cataracts?

Overall, the evidence does not support the use of these supplements specifically for the prevention of age-related cataracts.

A separate analysis of AREDS2 included over 3,000 people who had at least one natural lens at the start of the study. Lutein and zeaxanthin at doses of 10 and 2 mg, respectively, did not reduce the overall likelihood of cataract surgery or the risk of significant vision loss. [27]

An interesting finding emerged among participants with a particularly low dietary intake of lutein and zeaxanthin: this subgroup had a lower incidence of cataract surgery. However, this was a subgroup analysis and therefore not sufficient to recommend lutein supplementation for cataract prevention to all healthy individuals. [28]

Observational studies do often find a lower prevalence of some types of cataracts with higher blood levels of these carotenoids, but the observational association does not prove that the supplement itself prevents the disease.[29]

Should people who work a lot in front of a screen take lutein?

There is not yet enough evidence to recommend it to all computer and smartphone users.

Lutein and zeaxanthin do absorb some short-wavelength light, which is why supplements have been marketed as screen protectors. Some small, randomized studies of healthy people have shown increases in macular pigment and improvements in certain contrast tests after taking such supplements. [30]

However, changes in macular pigment do not prove the prevention of digital eye strain, myopia, or retinal damage. Moreover, typical computer eye fatigue is primarily due to infrequent blinking, dry eye surface, prolonged near-focusing, and workstation conditions, rather than lutein deficiency.

Therefore, for those whose eyes become dry or tired after using a screen, it's much more rational to first address visual strain, working distance, blinking, lighting, and, if necessary, vision correction. Lutein should not be used as a substitute for these measures.

Foods or supplements: what is preferable for a healthy person?

For a person without a specific ophthalmological indication, it is wiser to start with food.

The main sources of lutein are dark green leafy vegetables: spinach, kale, broccoli, and other green vegetables. Zeaxanthin is especially abundant in corn and some yellow and orange vegetables, and both carotenoids are present in egg yolk. [31]

The amount of carotenoids in a given food varies greatly depending on variety, ripeness, processing, and preparation, so tables listing the exact "lutein content of a single leaf of spinach" create a false sense of precision. A more general principle is a varied diet with both green leafy and colorful vegetables. [32]

Eggs contain lower absolute amounts of these carotenoids than some leafy vegetables, but their bioavailability can be quite high due to the food matrix and yolk fat. A meta-analysis of small clinical studies found that regular egg consumption increased blood lutein concentrations and macular pigment density. This doesn't mean eggs are a cure for macular degeneration, but it does show that it's possible to obtain bioavailable carotenoids from regular foods. [33]

The American Academy of Ophthalmology, in its current guidelines, also notes a link between a Mediterranean-style diet and a reduced risk of developing and progressing age-related macular degeneration. This is an observational association, but it supports the preference for a well-rounded diet over the "one-size-fits-all" approach. [34]

How much lutein and zeaxanthin do you need per day?

There is no official recommended daily intake (RDI) for the healthy population. The commonly used figures of 10 mg lutein and 2 mg zeaxanthin are primarily derived from the AREDS2 formula and do not represent a universal dietary intake for all adults. [35]

This is one of the most common sources of confusion. The AREDS2 formula used 10 mg and 2 mg because the researchers were testing a specific intervention in patients at high risk of disease progression. This doesn't mean that a healthy person is "insufficient" in lutein if they get, for example, 4 mg from food.

Systematic studies of healthy adults show that macular pigment can be increased at varying doses, with the effect being more pronounced at higher intakes. However, it remains unclear what the optimal macular pigment density is and whether increasing macular pigment above normal levels leads to clinically significant benefits in healthy individuals. [36]

Therefore, the AREDS2 dose should be used as the therapeutic study dose in a specific formula, rather than as the recommended daily amount of lutein and zeaxanthin for the population.

Can I take 20 mg of lutein instead of 10 mg?

High doses of lutein have been studied in clinical trials and are generally well tolerated, but more is not better.

A meta-analysis of studies in healthy eyes found a greater increase in macular pigment with total carotenoid doses of 20 mg/day, but the authors were unable to establish that such an increase necessarily translated into clinically significant improvements in vision.[37]

The European Food Safety Authority (EFSA) has established a tolerable daily intake (TDI) of 1 mg per kilogram of body weight for certain purified lutein preparations as part of its food coloring safety assessment. However, this value relates to toxicological safety, not the recommended dose for eye supplements. It should not be used as a target for daily intake. [38]

For a generally healthy person, there is no proven reason to increase the dose from 10 to 20 or 40 mg in an attempt to "accumulate more pigment." In cases of established macular degeneration, one should focus not on the maximum possible dose of a single lutein supplement, but on a formula studied in clinical trials.

How safe are lutein and zeaxanthin?

At the doses studied, these carotenoids were generally well tolerated. In AREDS2, no significant increase in serious adverse events was observed with the addition of lutein and zeaxanthin. Ten-year follow-up also found no increase in lung cancer risk, as observed with beta-carotene. [39]

However, the safety of lutein alone and the safety of the entire AREDS2 formula are not the same. The formula contains high doses of vitamin E and zinc, so it may interact with other supplements and medications. The National Eye Institute recommends discussing it with your doctor and disclosing any other vitamins and medications you are taking. [40]

It's especially undesirable to combine several eye supplements with a regular multivitamin without comparing the ingredients. This could result in a person adding zinc, vitamin E, or other ingredients, even though they thought they were simply increasing lutein.

How to choose the right supplement for macular degeneration

If an ophthalmologist has determined the stage of the disease for which the AREDS2 formula is indicated, one should focus not on the photograph of the eye on the packaging or the inscription "macula," but on the actual composition.

The National Eye Institute recommends checking it against a researched formula: 500 mg vitamin C, 400 international units vitamin E, 80 mg zinc, 2 mg copper, 10 mg lutein, and 2 mg zeaxanthin. Beta-carotene should not be present. [41]

Substituting a lutein + zeaxanthin capsule for a formula because it's cheaper or contains more lutein is not evidence-based. Large studies that have shown a reduced risk of disease progression examined a combination of antioxidants and minerals.

If a person has conditions for which high doses of individual components are undesirable, the choice of composition should be discussed with a doctor. A lower dose of zinc has also been studied in clinical trials, but the standard, widely used formula from the National Eye Institute still contains 80 mg. [42]

Is it possible to find out if your eyes are lacking lutein?

In normal clinical practice, there is no test after which the doctor says: “You have a lutein deficiency, you need 10 mg per day.”

Blood carotenoid levels or macular pigment optical density can be measured using specialized methods, and such measurements are widely used in research. However, they are not a standard way to determine the need for supplements in healthy individuals. [43]

The diagnosis of age-related macular degeneration is also not based on lutein levels. An ophthalmologist evaluates the retina after dilating the pupil and, if necessary, uses optical coherence tomography and other imaging techniques. The decision on the AREDS2 formula is based primarily on the stage of the disease, not on the concentration of carotenoids in the blood. [44]

What is often misunderstood

"Lutein is found in the macula, so it must be taken in pill form." No. The biological role of the substance does not equate to a proven need for additional supplementation. In healthy individuals, supplements increase macular pigment, but the clinical benefit of long-term prophylactic use remains uncertain. [45]

"AREDS2 proved that lutein prevents macular degeneration in healthy people." No. AREDS2 included people with intermediate or late-stage disease. People with healthy retinas were not included in this trial. [46]

"10 mg of lutein and 2 mg of zeaxanthin are the daily requirement for everyone." No. These are doses from the AREDS2 formula studied, not the established physiological requirement for a healthy person. [47]

"The more macular pigment, the better the vision." Not necessarily. There are statistical links between pigment density and some visual functions, but an increase in an intermediate biomarker does not guarantee disease prevention or a significant improvement in normal visual acuity. [48]

"Lutein prevents cataracts." In a large randomized trial, the overall risk of cataract surgery was not reduced.[49]

"Lutein supplementation protects against computer damage." There is insufficient clinical evidence for this. A few small studies show changes in macular pigment and contrast sensitivity, but this does not prove the prevention of digital eye strain or retinal disease. [50]

Practical Choice: Do You Need Them?

If the retina is healthy and an ophthalmologist has not diagnosed age-related macular degeneration, supplementation is usually not necessary. A diet rich in green leafy vegetables, colorful vegetables, and other whole foods allows you to obtain these carotenoids naturally. [51]

If early-stage age-related macular degeneration is diagnosed, don't jump on a high-dose formula just because the disease has already been diagnosed. Current guidelines do not yet consider AREDS2 a proven treatment for early-stage age-related macular degeneration, although new small studies are continuing to explore the potential benefits of carotenoids. [52]

In the intermediate or late stage of disease in one eye, the situation changes: here, it is worth specifically asking the ophthalmologist about the AREDS2 formula. In geographic atrophy, new data also support its use in some patients. [53]

If you're considering taking a supplement solely because you spend too much time in front of a computer screen, it's more practical to first address dryness, eyestrain, and vision correction. Lutein doesn't replace these measures.

Frequently Asked Questions

Should I take lutein after 50?

No, age alone is not an indication. If the retina is healthy, there is no evidence that prophylactic use of AREDS2 prevents the development of age-related macular degeneration. The decision depends on the condition of the macula, not the date of birth. [54]

And after 60 or 70 years

The principle is the same. The risk of disease does increase with age, so it's more important to have your retina checked regularly than to automatically start supplements.

Can I take just lutein and zeaxanthin instead of AREDS2?

In intermediate age-related macular degeneration, this is not a proven equivalent replacement. Large studies on reducing the risk of disease progression are focusing on the combination of antioxidants and AREDS2 minerals. [55]

Should a healthy person take 10 mg of lutein and 2 mg of zeaxanthin?

There is no established need. These amounts are derived from the AREDS2 scheme and are not official daily intakes for the healthy population.[56]

Can you get enough from food?

There is no specific target for healthy individuals to reach 10 mg. Lutein and zeaxanthin are found in green leafy vegetables, broccoli, corn, some colored vegetables, and egg yolks. [57]

Which is better - spinach or capsules?

For a healthy individual without established macular degeneration, a complete diet is preferable. In intermediate age-related macular degeneration, diet is not considered an equivalent replacement for the AREDS2 formula studied. [58]

Will supplements improve normal visual acuity?

In a healthy individual, no guaranteed improvement in standard visual acuity should be expected. Studies more often show changes in macular pigment, contrast, or recovery from bright light. [59]

Do they help with cataracts?

In the large AREDS2 study, no overall reduction in the risk of cataract surgery or vision loss was found.[60]

Do they help with dry eyes?

This is not a standard treatment for dry eye. Lutein and zeaxanthin are primarily studied in relation to the macula and retina, while dry eye is associated with the tear film and ocular surface.

Do phones protect against blue light?

They do enter the macular pigment, which absorbs some short-wavelength light, but there is insufficient clinical evidence that the capsules prevent eye damage from regular screens.

Can smokers take lutein?

Lutein and zeaxanthin have not been shown to increase the risk of lung cancer associated with high-dose beta-carotene. If a formula for macular degeneration is needed, the current AREDS2 does not contain beta-carotene and is preferable to the older formula for current and former smokers. [61]

Can I take AREDS2 without consulting a doctor?

It is best to first determine the stage of the disease. The formula contains high doses of several substances and is not intended for all patients with retinal changes. [62]

Key points from experts

Emily Chu is an ophthalmologist, retinal specialist, National Institutes of Health Distinguished Investigator, and Director of the Epidemiology and Clinical Research Branch at the National Eye Institute. She played a key role in the AREDS and AREDS2 trials and is a leading expert in age-related macular degeneration clinical research. [63]

In the National Eye Institute's official announcement of the 10-year follow-up, Chu explains that the goal of AREDS2 was to create a beta-carotene-free formula suitable for people with a history of smoking. Long-term follow-up confirmed that replacing beta-carotene with lutein and zeaxanthin was not only safer in terms of lung cancer risk but also somewhat more effective in slowing the progression of age-related macular degeneration. [64]

Tiarnan Keenan, MD, PhD, is an ophthalmologist and researcher at the National Eye Institute and an expert in retinal diseases and age-related macular degeneration. His research focuses on the natural history of the disease, geographic atrophy, and ways to slow its progression. [65]

In a 2024 National Eye Institute publication, Keenan notes that the results support the continued use of the AREDS2 formula in people with late-onset dry age-related macular degeneration. The effect was most pronounced when geographic atrophy lesions had not yet reached the very center of the macula, and the authors plan to confirm this finding in a separate study. [66]

Main

Lutein and zeaxanthin are indeed important components of macular pigment, but the need for supplementation depends on the clinical situation. Current guidelines do not recommend prophylactic use of AREDS2 for healthy individuals without age-related macular degeneration, and there is insufficient evidence that regular lutein capsules prevent eye disease. [67]

The most compelling clinical data exists for the full AREDS2 formula in intermediate age-related macular degeneration and some late-stage variants. The 10 mg lutein and 2 mg zeaxanthin doses should be understood in this context, not as a universal daily value. [68]

If your eyes are healthy, it's best to focus on a varied diet with green leafy and colorful vegetables and have regular eye exams based on your age and risk factors. If drusen or age-related macular degeneration has already been detected, the key question isn't whether lutein is beneficial at all, but rather what stage of the disease you're at and whether the proven AREDS2 formula is right for you.